Clinical Trial Update: Noninvasive Neuromodulation in the Management of Post-COVID Musculoskeletal Pain [NA]

View source ↗

Summary

A clinical trial is currently recruiting to evaluate noninvasive neuromodulation as a treatment for post-COVID musculoskeletal pain. The sponsor is the Universi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Musculoskeletal Pain

Snippet

Sponsor: University of Alcala | Conditions: COVID-19, Musculoskeletal Pain | NA | Status: RECRUITING